{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:22:02Z","timestamp":1794270122726,"version":"4.9.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijantimicag.2026.107956","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:09:02Z","timestamp":1786374542000},"page":"107956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of timing of aggressive joint PK\/PD target attainment of continuous infusion piperacillin-tazobactam on early clinical response of febrile neutropenia to antimicrobial treatment: Insights from a prospective, monocentric, observational study in paediatric hematopoietic stem cell recipients"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-3779","authenticated-orcid":false,"given":"Milo","family":"Gatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-5876","authenticated-orcid":false,"given":"Davide","family":"Leardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-639X","authenticated-orcid":false,"given":"Caterina","family":"Campoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-3713","authenticated-orcid":false,"given":"Francesco","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Patrucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Belotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Baccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Giannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Lanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-7167","authenticated-orcid":false,"given":"Federico","family":"Pea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107956_bib0001","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(20)30725-7","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Lehrnbecher","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13054-024-04911-5","article-title":"Impact of attaining aggressive vs. conservative PK\/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis","volume":"28","author":"Gatti","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0003","article-title":"Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever","volume":"5","author":"Maarbjerg","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0004","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/INF.0b013e318298dfb8","article-title":"Optimization of continuous infusion of piperacillin\u2013tazobactam in children with fever and neutropenia","volume":"32","author":"Delvall\u00e9e","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.768438","article-title":"Ensuring sufficient trough plasma concentrations for broad-spectrum beta-lactam antibiotics in children with malignancies: beware of augmented renal clearance!","volume":"9","author":"Andr\u00e9","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0006","first-page":"177","article-title":"Marrow engraftment and clinical manifestations of capillary leak syndrome","volume":"18","author":"Cahill","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0007","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/jac\/dkv123","article-title":"Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial","volume":"70","author":"Sime","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0008","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0009","unstructured":"Children\u2019s Health Queensland. Management of fever in a paediatric oncology patient - febrile neutropenia and febrile non-neutropenia, https:\/\/www.childrens.health.qld.gov.au\/__data\/assets\/pdf_file\/0024\/176910\/gdl-fever-oncology.pdf; 2025 [accessed 13.08.26]."},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/antibiotics11040458","article-title":"Stability studies of 16 antibiotics for continuous infusion in intensive care units and for performing outpatient parenteral antimicrobial therapy","volume":"11","author":"Loeuille","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116119","article-title":"Development of a rapid LC-MS\/MS method for simultaneous quantification of ten commonly used antibiotic drugs in human serum","volume":"244","author":"Ramirez","year":"2024","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/31.suppl_A.39","article-title":"The chemistry, pharmacokinetics and tissue distribution of piperacillin\/tazobactam","volume":"31","author":"S\u00f6rgel","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0013","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1093\/infdis\/jiaf048","volume":"232","author":"Gatti","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0014","doi-asserted-by":"crossref","first-page":"e01906","DOI":"10.1128\/AAC.01906-18","article-title":"Optimal piperacillin-tazobactam dosing strategies against extended-spectrum-\u03b2-lactamase-producing enterobacteriaceae","volume":"63","author":"Abodakpi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0015","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1128\/AAC.02635-15","article-title":"Combinatorial pharmacodynamics of ceftolozane-tazobactam against genotypically defined \u03b2-lactamase-producing Escherichia coli: insights into the pharmacokinetics\/pharmacodynamics of \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations","volume":"60","author":"Soon","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/microorganisms12010151","volume":"12","author":"Gatti","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0017","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmi.2024.10.006","article-title":"Efficacy of extended infusion of \u03b2-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial","volume":"31","author":"Laporte-Amargos","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0019","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027266","article-title":"Comparative efficacy and safety of antipseudomonal \u03b2-lactams for pediatric febrile neutropenia: a systematic review and Bayesian network meta-analysis","volume":"100","author":"Tan","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7307","article-title":"Assessment value of interleukin-6, procalcitonin, and C-reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: a prospective study","volume":"13","author":"Zheng","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0021","doi-asserted-by":"crossref","first-page":"e01404","DOI":"10.1128\/aac.01404-23","article-title":"Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin\/tazobactam against extended spectrum beta-lactamase producing Enterobacterales","volume":"68","author":"Cojutti","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0022","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/08971900221121362","article-title":"Augmented renal clearance in the hematology and oncology populations: a scoping review for pharmacists","volume":"36","author":"Nelson","year":"2023","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.ijantimicag.2026.107956_bib0023","first-page":"33","article-title":"Age-related changes in renal reserve and renal tubular function in healthy humans","volume":"11","author":"DeSanto","year":"1991","journal-title":"Child Nephrol Urol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:37:03Z","timestamp":1794267423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0924857926002438"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107956","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of timing of aggressive joint PK\/PD target attainment of continuous infusion piperacillin-tazobactam on early clinical response of febrile neutropenia to antimicrobial treatment: Insights from a prospective, monocentric, observational study in paediatric hematopoietic stem cell recipients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107956"}}